Verus Capital Partners’s Cambria Cannabis ETF TOKE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$6K Sell
561
-520
-48% -$6.84K ﹤0.01% 1150
2019
Q4
$16K Buy
+1,081
New +$17.8K 0.01% 980

Other funds holding TOKE

Verus Capital Partners's TOKE Position: Q1 2020 in Review

Verus Capital Partners reduced its Cambria Cannabis ETF (TOKE) stake by 48% in Q1 2020, selling an estimated $6.84K and leaving 561 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1150.

Verus Capital Partners first reported a position in TOKE in Q4 2019 and has held it in 2 quarters since. The position peaked at $16K in Q4 2019. 14 funds tracked by Wall St. Rank hold TOKE as of Q1 2020.

  • Verus Capital Partners held 561 shares of Cambria Cannabis ETF worth $6K as of Q1 2020.
  • Verus Capital Partners sold 520 Cambria Cannabis ETF shares in Q1 2020, an estimated $6.84K.
  • Cambria Cannabis ETF made up ﹤0.01% of Verus Capital Partners's portfolio in Q1 2020, its #1150 holding.
  • Verus Capital Partners first reported a position in Cambria Cannabis ETF in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's Cambria Cannabis ETF position peaked at $16K in Q4 2019.
  • 14 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.